Abstract:Neurodegenerative diseases are becoming prevalent as the population ages. Geniposide could inhibit oxidative stress, reduce apoptosis, protect neuron, and has been used for therapy of the neurodegenerative diseases. The bioavailability of geniposide by nasal route is greater than that by oral administration. However, mucociliary clearance is a rate-limiting factor for nasal route administration. The objective of this study was to develop and evaluate a mucoadhesive, thermoreversible in situ nasal gel of geniposide. The poloxamers (P407, P188) and the hydroxypropyl methylcellulose were used as thermoreversible and mucoadhesive polymers, respectively. Borneol was used as a permeation enhancer. The hydrogel was prepared with the cold method and optimized by the response surface methodology-central composite design. Gelation temperature, pH, clarity, gel strength, mucoadhesive strength, in vitro and ex vivo release kinetics of formulations were evaluated. The optimized amounts of poloxamer407 (P407), poloxamer188 (P188) and hydroxypropyl methylcellulose were determined to be 19.4-20.5%, 1.1-4.0% and 0.3-0.6% respectively. The second-order polynomial equation in terms of actual factors indicated a satisfactory correlation between the independent variables and the response (R2 = 0.9760). An ANOVA of the empirical second-order polynomial model indicated the model was significant (P<0.01). P407, P188, P407×P188, P4072 and P1882 were significant model terms. The effects of P407 on gelation temperature were greater than those of other independent variables. The pH values of all the formulations were found to be within 6.3-6.5 which was in the nasal physiological pH range 4.5-6.5. The drug content, gel strength, mucoadhesive strength of the optimized formulations were 97-101%, 25-50 sec and 4000-6000 dyn/cm2 respectively. The in vitro release kinetics of cumulative release of geniposide was fitted to the zero-order model. The ex vivo cumulative release kinetics of geniposide was fitted to the Weibull model. This study concludes that the release of geniposide is controlled by gel corrosion, and that the permeation of geniposide is time-dependent. The more residence time, mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases is of compliance and potential application.

Comparative Study on Rat in Situ Nasal Absorption of Geniposide of Xingnaojing Nasal Drop and Xingnaojing Microemulsion

Study on pharmacokinetics of geniposide in mice administrated by Xingnaojing microemulsion and mPEG2000-PLA modified Xingnaojing microemulsion

Pharmacokinetics of Ginsenosides Rg1, Re and Notoginsenoside R1 in Rats by an in vivo Microdialysis Coupled with Liquid Chromatography/Mass Spectrometry

Nasal administration of Xingnaojing biomimetic nanoparticles for the treatment of ischemic stroke

Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration

Preparation, In Vitro and In Vivo Evaluation of Nanoemulsion In Situ Gel for Transnasal Delivery of Traditional Chinese Medicine Volatile Oil from Ligusticum sinense Oliv.cv. Chaxiong

Pharmacokinetic and pharmacodynamic study of Panax notoginseng saponins nasal gel spray

Comparative study on absorption of Luodian Borneolum and muscone after nasal unidirectional perfusion with different Xingnaojing preparations in rats

[The Pharmacokinetics and Pharmacodynamics of Intranasal Preparation of Panax Notoginseng Saponins].

[Study on Nasal Absorption of Cistanche Deserticola Phenylethanol Glycosides Nanoemulsion in Vivo].

Pharmacokinetics and Brain-targeting Ability of Gastrodin Nasal in Situ Gel in Rats

Study on Pharmacokinetics and Bioavailability of Nimodipine Nanostructured Lipid Carrier in Rats

The Brain Targeting Efficiency Following Nasally Applied Mpeg-Pla Nanoparticles In Rats

Preparation of Mpeg2000-Pla-modified Xingnaojing Microemulsion and Evaluation in Mucosal Irritation.

Distribution of Nimodipine in Brain Following Intranasal Administration in Rats

A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases

Influence of Glycerol/Dimethylsulfoxide Homogeneous Solution on PNS Bioavailability in rats

Study on treatment of AD by NGF liposomes via nasal administration

Study on brain drug concentration of geniposide in mice after iv injected with Xingnaojing Injection and its pharmacokinetics

Preparation of Nimodipine-Loaded Microemulsion for Intranasal Delivery and Evaluation on the Targeting Efficiency to the Brain

Evaluation of intestinal absorption of ginsenoside Rg1 incorporated in microemulison using parallel artificial membrane permeability assay.